GlassScriptPhysician profile
Marisa Deliso
NPI 1710507199
$5,753.61
in general payments reported to CMS, 2019-2025
6 companies · $5,740 in 2025
The $5,740 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $13.97 · 2025: $5,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $471 · Education: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $471.15 |
| Education | $282.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,311.20 | 2025 | Q-Fix, Healicoil, Kvac |
| Reel Surgical, INC. | $227.36 | 2025 | |
| Stryker Corporation | $134.75 | 2025 | Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $48.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.33 | 2025 | |
| Glaxosmithkline, LLC. | $13.97 | 2024 | Ojjaara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Deliso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.